SEC Filing Summary: AspenBio Pharma, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by AspenBio Pharma, Inc. on May 17, 2006. The registrant is incorporated in Colorado with its principal executive offices in Castle Rock, CO. Note: The request metadata referenced "Riot Platforms, Inc.", but the provided filing text explicitly identifies the registrant as AspenBio Pharma, Inc.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that a press release containing results of operations and financial condition was issued on the date of the report.
Material Changes
Item 2.02 indicates the issuance of a press release regarding Results of Operations and Financial Condition. Item 7.01 indicates Regulation FD Disclosure. The specific material changes or financial results are contained in the press release furnished as Exhibit 99.1, which is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These details are referenced as being part of the press release in Exhibit 99.1.
Investor Verification Checklist
- Verify the actual financial results and operational metrics in the press release attached as Exhibit 99.1.
- Confirm the discrepancy between the request metadata (Riot Platforms, Inc.) and the filing registrant (AspenBio Pharma, Inc.).
- Review the full text of the May 17, 2006 press release for specific details on revenue, earnings, and forward-looking statements.